Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, Radiopharmaceutical Chemistry and Applications, and Neuroendocrine Tumor Research Advances.
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition
Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer
Replication and single-cycle delivery of SARS-CoV-2 replicons
Rlf–Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer
DSpace@MIT (Massachusetts Institute of Technology) 2021cited by 43position: middle
Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry
Synthesis and Comparative <i>In Vivo</i> Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET
Regenerative lineages and immune-mediated pruning in lung cancer metastasis
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
Emergence of a High-Plasticity Cell State during Lung Cancer Evolution
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
Lineage Reversion Drives WNT Independence in Intestinal Cancer
Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics
Epigenetic CRISPR Screens Identify <i>Npm1</i> as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer
Single cell profiling reveals novel tumor and myeloid subpopulations in small cell lung cancer
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
ONECUT2 is a driver of neuroendocrine prostate cancer
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers
Research at Ultra High Energies
Research at Ultra High Energies
Research at Ultra High Energy Cosmic Rays and Particle Physics
Research in Elementary Particle Physics
Research in Elementary Particle Physics
Research in Elementary Particle Physics
Elementary Particle Physics
Elementary Particle Physics
Elementary Particle Physics